|Articles|August 15, 2003

Dry-eye treatment drops under review by FDA

Durham, NC-Inspire Pharmaceuticals Inc. is asking the FDA for approval to market diquafosol tetrasodium (INS365) eye drops in a 2% preservative-free solution for the treatment of dry eye.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME